Consumer Inquiries: 888-INFO-FDA, DICE@fda.hhs.gov FDA issues proposals to address risks associated with surgical mesh for transvaginal repair of pelvic organ prolapse The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify […]Read More